Articles by K. L Lee (3)

Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population

W. C Levy, K. L Lee, A. S Hellkamp, J. E Poole, D Mozaffarian, D. T Linker, A. P Maggioni, I Anand, P. A Poole Wilson, D. P Fishbein, G Johnson, J Anderson, D. B Mark and G. H. Bardy

Circulation 120 ( 10 ): 835 - 842 , 2009

Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure: Analysis From the Sudden Cardiac Death in Heart Failure Trial

D. L Packer, J. M Prutkin, A. S Hellkamp, L. B Mitchell, R. C Bernstein, F Wood, J. P Boehmer, M. D Carlson, R. P Frantz, S. E McNulty, J. G Rogers, J Anderson, G. W Johnson, M. N Walsh, J. E Poole, D. B Mark, K. L Lee and G. H. Bardy

Circulation 120 ( 22 ): 2170 - 2176 , 2009

A Model for Predicting Mortality in Acute ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Results From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

A Stebbins, R. H Mehta, P. W Armstrong, K. L Lee, C Hamm, F Van de Werf, S James, T Toftegaard Nielsen, R Seabra Gomes, H. D White, C. B Granger and for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI Investigators)

Circulation: Cardiovascular Interventions 3 ( 5 ): 414 - 422 , 2010

Do you have a suggestion for journals

Suggest Journal